These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 3004711
1. Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. Glisson B, Gupta R, Smallwood-Kentro S, Ross W. Cancer Res; 1986 Apr; 46(4 Pt 2):1934-8. PubMed ID: 3004711 [Abstract] [Full Text] [Related]
2. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Glisson B, Gupta R, Hodges P, Ross W. Cancer Res; 1986 Apr; 46(4 Pt 2):1939-42. PubMed ID: 3004712 [Abstract] [Full Text] [Related]
3. Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase. Glisson BS, Sullivan DM, Gupta R, Ross WE. NCI Monogr; 1987 Apr; (4):89-93. PubMed ID: 2819738 [Abstract] [Full Text] [Related]
4. Topoisomerase II-dependent and -independent mechanisms of etoposide resistance in Chinese hamster cell lines. Spiridonidis CA, Chatterjee S, Petzold SJ, Berger NA. Cancer Res; 1989 Feb 01; 49(3):644-50. PubMed ID: 2535964 [Abstract] [Full Text] [Related]
5. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB. Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249 [Abstract] [Full Text] [Related]
7. Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A. Cancer Res; 1986 Jun 01; 46(6):3075-81. PubMed ID: 3009009 [Abstract] [Full Text] [Related]
8. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Sullivan DM, Latham MD, Ross WE. Cancer Res; 1987 Aug 01; 47(15):3973-9. PubMed ID: 3038304 [Abstract] [Full Text] [Related]
9. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Wolverton JS, Danks MK, Schmidt CA, Beck WT. Cancer Res; 1989 May 01; 49(9):2422-6. PubMed ID: 2539902 [Abstract] [Full Text] [Related]
10. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line. Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC. Mol Pharmacol; 1993 Feb 01; 43(2):207-16. PubMed ID: 8094226 [Abstract] [Full Text] [Related]
11. Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Gupta RS, Gupta R, Eng B, Lock RB, Ross WE, Hertzberg RP, Caranfa MJ, Johnson RK. Cancer Res; 1988 Nov 15; 48(22):6404-10. PubMed ID: 2846151 [Abstract] [Full Text] [Related]
12. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants. Liu SY, Hwang BD, Haruna M, Imakura Y, Lee KH, Cheng YC. Mol Pharmacol; 1989 Jul 15; 36(1):78-82. PubMed ID: 2546053 [Abstract] [Full Text] [Related]
13. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Holm C, Covey JM, Kerrigan D, Pommier Y. Cancer Res; 1989 Nov 15; 49(22):6365-8. PubMed ID: 2553254 [Abstract] [Full Text] [Related]
14. Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Sullivan DM, Latham MD, Rowe TC, Ross WE. Biochemistry; 1989 Jun 27; 28(13):5680-7. PubMed ID: 2550059 [Abstract] [Full Text] [Related]
15. Reduced topoisomerase II-mediated DNA cleavage in VP-16 resistant human leukemic cell line. Saijo Y, Satoh K, Tokue Y, Kumano N, Motomiya M. Anticancer Res; 1991 Jun 27; 11(1):445-8. PubMed ID: 1850222 [Abstract] [Full Text] [Related]
16. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines. Rothenborg-Jensen L, Hansen HF, Wessel I, Nitiss JL, Schmidt G, Jensen PB, Sehested M, Jensen LH. Anticancer Drug Des; 2001 Dec 27; 16(6):305-15. PubMed ID: 12375883 [Abstract] [Full Text] [Related]
17. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH. Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202 [Abstract] [Full Text] [Related]
18. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW. Cancer Res; 1986 Feb 01; 46(2):611-6. PubMed ID: 3000581 [Abstract] [Full Text] [Related]
19. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line. Kim HK, Zwelling LA, Sacks PG, Hong WK, Chan D, Silberman L, Glisson BS. Cancer Res; 1989 Mar 01; 49(5):1197-201. PubMed ID: 2537145 [Abstract] [Full Text] [Related]
20. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomerase II inhibitors and cross-resistant to peroxides. Davies SM, Davies SL, Harris AL, Hickson ID. Cancer Res; 1989 Aug 15; 49(16):4526-30. PubMed ID: 2545343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]